Detection and Measurement of Staphylococcal Enterotoxin-Like K (SEl-K) Secretion by Staphylococcus aureus Clinical Isolates
Open Access
- 1 July 2014
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 52 (7) , 2536-2543
Abstract
Staphylococcal enterotoxin-like K (SEl-K) is a potent mitogen that elicits T-cell proliferation and cytokine production at very low concentrations. However, unlike the classical enterotoxins SEB and toxic shock syndrome toxin 1 (TSST-1), the gene for SEl-K is commonly present in more than half of all Staphylococcus aureus clinical isolates and is present in almost all USA300 community-acquired methicillin-resistant S. aureus (CA-MRSA) isolates. Sequencing of the sel-k gene in over 20 clinical isolates and comparative analysis with all 14 published sel-k sequences indicate that there are at least 6 variants of the sel-k gene, including one that is conserved among all examined USA300 strains. Additionally, we have developed a highly sensitive enzyme-linked immunosorbent assay (ELISA) that specifically detects and measures SEl-K protein in culture supernatants and biological fluids. Quantification of in vitro SEl-K secretion by various S. aureus isolates using this novel capture ELISA revealed detectable amounts of SEl-K secretion by all isolates, with the highest secretion levels being exhibited by MRSA strains that coexpress SEB. In vivo secretion was measured in a murine thigh abscess model, where similar levels of SEl-K accumulation were noted regardless of whether the infecting strain exhibited high or low secretion of SEl-K in vitro . We conclude that SEl-K is commonly expressed in the setting of staphylococcal infection, in significant amounts. SEl-K should be further explored as a target for passive immunotherapy against complicated S. aureus infection.Keywords
This publication has 46 references indexed in Scilit:
- Staphylococcus aureus Isolates Encode Variant Staphylococcal Enterotoxin B Proteins That Are Diverse in Superantigenicity and LethalityPLOS ONE, 2012
- Genotypes and Toxin Gene Profiles of Staphylococcus aureus Clinical Isolates from ChinaPLOS ONE, 2011
- Chimeric Anti-Staphylococcal Enterotoxin B Antibodies and Lovastatin Act Synergistically to Provide In Vivo Protection against Lethal Doses of SEBPLOS ONE, 2011
- Generation, Characterization, and Epitope Mapping of Neutralizing and Protective Monoclonal Antibodies against Staphylococcal Enterotoxin B-induced Lethal ShockJournal of Biological Chemistry, 2011
- Inhibition of Toxic Shock by Human Monoclonal Antibodies against Staphylococcal Enterotoxin BPLOS ONE, 2010
- Virulence Genes and Genotypic Associations in Nasal Carriage, Community-Associated Methicillin-Susceptible and Methicillin-Resistant USA400 Staphylococcus aureus IsolatesJournal of Clinical Microbiology, 2010
- Potent Neutralization of Staphylococcal Enterotoxin B by Synergistic Action of Chimeric AntibodiesInfection and Immunity, 2010
- Diverse Enterotoxin Gene Profiles among Clonal Complexes of Staphylococcus aureus Isolates from the Bronx, New YorkApplied and Environmental Microbiology, 2009
- Measurement of Staphylococcal Enterotoxin B in Serum and Culture Supernatant with a Capture Enzyme-Linked Immunosorbent AssayClinical and Vaccine Immunology, 2007
- A Novel Loop Domain in Superantigens Extends their T Cell Receptor Recognition SiteJournal of Molecular Biology, 2007